Back To Index  <<  Back To Terminology

final Value Set ELGA_whoATC 2013‑01‑10

Diese Terminologie ist eine Momentaufnahme vom 2023‑03‑17 08:23:48. Terminologien können sich im Laufe der Zeit weiterentwickeln. Wenn eine neuere (dynamische) Versionen dieser Terminologie benötigt wird, bitte von der Quelle abrufen.
Id 1.2.40.0.34.10.73 Gültigkeit 2013‑01‑10
Status final Definitiv Versions-Label
Name ELGA_whoATC Bezeichnung ELGA_whoATC
Beschreibung ELGA Valueset für ATC
Quell-Codesystem
2.16.840.1.113883.6.73 - WHO Anatomical Therapeutic Chemical classification - FHIR: http://www.whocc.no/atc - HL7 V2: WC
Level/ Typ Code Bezeichnung Codesystem
0‑L
A
Alimentäres System und Stoffwechsel
WHO Anatomical Therapeutic Chemical classification
0‑L
A01
Stomatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
A01a
Stomatologika
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA
Mittel zur Kariesprophylaxe
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA01
Natriumfluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA02
Natriummonofluorphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA03
Olaflur
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA04
Zinn(II)-fluorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AA51
Natriumfluorid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB
Antiinfektiva und Antiseptika zur oralen Lokalbehandlung
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB02
Wasserstoffperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB03
Chlorhexidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB04
Amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB05
Polynoxylin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB06
Domiphen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB07
Oxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB08
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB09
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB10
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB11
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB12
Hexetidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB13
Tetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB14
Benzoxoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB15
Tibezoniumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB16
Mepartricin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB17
Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB18
Clotrimazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB19
Natriumperborat
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB21
Chlortetracyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB22
Doxycyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AB23
Minocyclin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC
Corticosteroide zur oralen Lokalbehandlung
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC01
Triamcinolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC02
Dexamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC03
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AC54
Prednisolon, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD
Andere Mittel zur oralen Lokalbehandlung
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD01
Epinephrin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD02
Benzydamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD05
Acetylsalicylsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD06
Adrenalon
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD07
Amlexanox
WHO Anatomical Therapeutic Chemical classification
0‑L
A01AD11
Verschiedene
WHO Anatomical Therapeutic Chemical classification
0‑L
A02
Mittel bei säure bedingten Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02A
Antacida
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA
Magnesium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA01
Magnesiumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA02
Magnesiumoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA03
Magnesiumperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA04
Magnesiumhydroxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA05
Magnesiumsilikat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AA10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB
Aluminium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB01
Aluminiumhydroxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB02
Algeldrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB03
Aluminiumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB04
Dihydroxyalumiumnatriumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB05
Aluminiumacetoacetat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB06
Aloglutamol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB07
Aluminiumglycinat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AB10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC
Calcium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC01
Calciumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC02
Calciumsilikat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AC10
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD
Kombinationen und Komplexe von Aluminium-, Calcium- und Magnesium-haltigen Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD01
Einfache Salzkombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD02
Magaldrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD03
Almagat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD04
Hydrotalcit
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AD05
Almasilat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF
Antacida mit Karminativa
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF01
Magaldrat und Karminativa
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AF02
Einfache Salzkombinationen und Karminativa
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AG
Antacida mit Spasmolytika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AH
Antacida mit Natriumbicarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02AX
Antacida, andere Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02B
Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA
Histamin-H2-Rezeptorantagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA01
Cimetidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA02
Ranitidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA03
Famotidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA04
Nizatidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA05
Niperotidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA06
Roxatidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA07
Ranitidinbismutcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA08
Lafutidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA51
Cimetidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BA53
Famotidin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB
Prostaglandine
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB01
Misoprostol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BB02
Enprostil
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC
Protonenpumpenhemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC01
Omeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC02
Pantoprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC03
Lansoprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC04
Rabeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC05
Esomeprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BC06
Dexlansoprazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD
Kombinationen zur Eradikation von Helicobacter pylori
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD01
Omeprazol, Amoxicillin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD02
Lansoprazol, Tetracyclin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD03
Lansoprazol, Amoxicillin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD04
Pantoprazol, Amoxicillin und Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD05
Omeprazol, Amoxicillin und Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD06
Esomeprazol, Amoxicillin und Clarithromycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BD08
Bismutsubcitrat, Tetracyclin und Metronidazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX
Andere Mittel bei peptischem Ulkus und gastroesophagealer Refluxkrankheit
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX01
Carbenoxolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX02
Sucralfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX03
Pirenzepin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX04
Methiosulfoniumchlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX05
Bismutsubcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX06
Proglumid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX07
Gefarnat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX08
Sulglicotid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX09
Acetoxolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX10
Zolimidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX11
Troxipid
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX12
Bismutsubnitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX13
Alginsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX51
Carbenoxolon, Kombinationen exkl. Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX71
Carbenoxolon, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02BX77
Gefarnat, Kombinationen mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A02X
Andere Mittel bei säure bedingten Erkrankungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03
Mittel bei funktionellen gastrointestinalen Störungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03A
Mittel bei funktionellen Störungen des Darms
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA
Synthetische Anticholinergika, Ester mit tertiären Aminogruppen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA01
Oxyphencyclimin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA03
Camylofin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA04
Mebeverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA05
Trimebutin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA06
Rociverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA07
Dicycloverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA08
Dihexyverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA09
Difemerin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AA30
Piperidolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB
Synthetische Anticholinergika, quartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB01
Benzilon
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB02
Glycopyrronium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB03
Oxyphenonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB04
Penthienat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB05
Propanthelin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB06
Otiloniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB07
Methanthelinium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB08
Tridihexethyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB09
Isopropamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB10
Hexocyclium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB11
Poldin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB12
Mepenzolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB13
Bevonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB14
Pipenzolat
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB15
Diphemanil
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB16
(2-Benzhydryloxyethyl)diethylmethyl-ammoniumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB17
Tiemoniumiodid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB18
Prifiniumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB19
Timepidiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB21
Fenpiverinium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AB53
Oxyphenonium, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC
Synthetische Spasmolytika, Amide mit tertiären Aminen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC02
Dimethylaminopropionylphenothiazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC04
Nicofetamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AC05
Tiropramid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD
Papaverin und Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD01
Papaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD02
Drotaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AD30
Moxaverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE
Auf Serotonin-Rezeptoren wirkende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE01
Alosetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE02
Tegaserod
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AE03
Cilansetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX
Andere Mittel bei funktionellen Störungen des Darms
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX01
Fenpipran
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX02
Diisopromin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX03
Chlorbenzoxamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX04
Pinaverium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX05
Fenoverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX06
Idanpramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX07
Proxazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX08
Alverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX09
Trepibuton
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX10
Isomethepten
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX11
Caroverin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX12
Phloroglucinol
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX13
Silikone
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX30
Trimethyldiphenylpropylamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03AX58
Alverin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03B
BELLADONNA UND DERIVATE, REIN
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA
Belladonna-Alkaloide, tertiäre Amine
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA01
Atropin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA03
Hyoscyamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BA04
Belladonna-Gesamtalkaloide
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB
Belladonna-Alkaloide, halbsynthetisch, quartäre Ammonium-Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB01
Butylscopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB02
Methylatropin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB03
Methylscopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB04
Fentonium
WHO Anatomical Therapeutic Chemical classification
0‑L
A03BB05
Cimetropiumbromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03C
Spasmolytika in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA
Synthetische Anticholinergika in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA01
Isopropamid und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA02
Clidinium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA03
Oxyphencyclimin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA04
Otiloniumbromid und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA05
Glycopyrronium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA06
Bevonium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA07
Ambutonium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA08
Diphemanil und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA30
Emepronium und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CA34
Propanthelin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB
Belladonna und Derivate in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB01
Methylscopolamin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB02
Belladonna-Gesamtalkaloide und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB03
Atropin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB04
Methylhomatropin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CB31
Hyoscyamin und Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03CC
Andere Spasmolytika in Kombination mit Psycholeptika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03D
Spasmolytika in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA
Synthetische Anticholinergika in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA01
Tropenzilon und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA02
Pitofenon und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA03
Bevonium und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA04
Ciclonium und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA05
Camylofin und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA06
Trospium und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DA07
Tiemoniumiodid und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DB
Belladonna und Derivate in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DB04
Butylscopolamin und Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03DC
Andere Spasmolytika in Kombination mit Analgetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03E
Spasmolytika und Anticholinergika in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
A03EA
Spasmolytika, Psycholeptika und Analgetika in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A03ED
Spasmolytika in Kombination mit anderen Mitteln
WHO Anatomical Therapeutic Chemical classification
0‑L
A03F
Prokinetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA
Prokinetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA01
Metoclopramid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA02
Cisaprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA03
Domperidon
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA04
Bromoprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA05
Alizaprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A03FA06
Cleboprid
WHO Anatomical Therapeutic Chemical classification
0‑L
A04
Antiemetika und Mittel gegen Übelkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
A04A
Antiemetika und Mittel gegen Übelkeit
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA
Serotonin-5HT3-Antagonisten
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA01
Ondansetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA02
Granisetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA03
Tropisetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA04
Dolasetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AA05
Palonosetron
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD
Andere Antiemetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD01
Scopolamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD02
Ceriumoxalat
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD04
Chlorbutanol
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD05
Metopimazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD10
Dronabinol
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD11
Nabilon
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD12
Aprepitant
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD51
Scopolamin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A04AD54
Chlorbutanol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A05
Gallen- und Lebertherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05A
Gallentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA
Gallensäure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA01
Chenodeoxycholsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AA02
Ursodeoxycholsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AB
Zubereitungen zur Gallentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AB01
N-(Hydroxymethyl)nicotinamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX
Andere Mittel zur Gallentherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX01
Piprozolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX02
Hymecromon
WHO Anatomical Therapeutic Chemical classification
0‑L
A05AX03
Cyclobutyrol
WHO Anatomical Therapeutic Chemical classification
0‑L
A05B
Lebertherapie, Lipotrope Substanzen
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA
Lebertherapie
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA01
Argininglutamat
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA03
Silymarin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA04
Citiolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA05
Epomediol
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA06
Ornithinoxoglurat
WHO Anatomical Therapeutic Chemical classification
0‑L
A05BA07
Tidiacicarginin
WHO Anatomical Therapeutic Chemical classification
0‑L
A05C
Mittel zur Gallentherapie und Lipotrope Substanzen in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06
Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06A
Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA
Gleitmittel, Emollientia
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA01
Dickflüssiges Paraffin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA02
Docusat-Natrium
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AA51
Dickflüssiges Paraffin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB
Kontaktlaxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB01
Oxyphenisatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB02
Bisacodyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB03
Dantron
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB04
Phenolphthalein
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB05
Rizinusöl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB06
Sennoside
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB07
Cascara
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB08
Natriumpicosulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB09
Bisoxatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB20
Kontaktlaxanzien in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB30
Kontaktlaxanzien in Kombination mit Belladonna-Alkaloiden
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB52
Bisacodyl, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB53
Dantron, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB56
Sennoside, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB57
Cascara, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AB58
Natriumpicosulfat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC
Quellmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC01
Ispaghula (Flohsamen)
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC02
Ethulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC03
Sterculia
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC05
Leinsamen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC06
Methylcellulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC07
Triticum (Weizenkleie)
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC08
Polycarbophil-Calcium
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC51
Ispaghula, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC53
Sterculia, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AC55
Leinsamen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD
Osmotisch wirkende Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD01
Magnesiumcarbonat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD02
Magnesiumoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD03
Magnesiumperoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD04
Magnesiumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD10
Mineralsalze in Kombination
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD11
Lactulose
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD12
Lactitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD13
Natriumsulfat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD14
Pentaerythrityl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD15
Macrogol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD16
Mannitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD17
Natriumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD18
Sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD19
Magnesiumcitrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD21
Natriumtartrat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD61
Lactulose, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AD65
Macrogol, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG
Klysmen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG01
Natriumphosphat
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG02
Bisacodyl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG03
Dantron, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG04
Glycerol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG06
Öl
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG07
Sorbitol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG10
Docusat-Natrium, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG11
Laurylsulfat, inkl. Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AG20
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AH01
Methylnaltrexon bromid
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX
Andere Laxanzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX01
Glycerol
WHO Anatomical Therapeutic Chemical classification
0‑L
A06AX02
Kohlendioxid-freisetzende Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A07
Antidiarrhoika und intestinale Antiphlogistika/Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
A07A
Intestinale Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA
Antibiotika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA01
Neomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA02
Nystatin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA03
Natamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA04
Streptomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA05
Polymyxin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA06
Paromomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA07
Amphotericin B
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA08
Kanamycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA09
Vancomycin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA10
Colistin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA11
Rifaximin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA12
Fidaxomicin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA51
Neomycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AA54
Streptomycin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB
Sulfonamide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB02
Phthalylsulfathiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB03
Sulfaguanidin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AB04
Succinylsulfathiazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AC
Imidazol-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AC01
Miconazol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX
Andere intestinale Antiinfektiva
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX01
Broxychinolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX02
Acetarsol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX03
Nifuroxazid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07AX04
Nifurzid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07B
Intestinale Adsorbenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA
Kohle-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA01
Medizinische Kohle
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BA51
Medizinische Kohle, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BB
Bismut-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC
Andere intestinale Adsorbenzien
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC01
Pektin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC02
Kaolin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC03
Crospovidon
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC04
Attapulgit
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC05
Diosmectit
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07BC54
Attapulgit, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07C
Elektrolyte mit Kohlenhydraten
WHO Anatomical Therapeutic Chemical classification
0‑L
A07CA
Elektrolyte zur oralen Rehydrierung
WHO Anatomical Therapeutic Chemical classification
0‑L
A07D
Motilitätshemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA
Motilitätshemmer
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA01
Diphenoxylat
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA02
Opium
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA03
Loperamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA04
Difenoxin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA05
Loperamidoxid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA52
Morphin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07DA53
Loperamid, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07E
Intestinale Antiphlogistika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA
Corticosteroide mit lokaler Wirkung
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA01
Prednisolon
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA02
Hydrocortison
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA03
Prednison
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA04
Betamethason
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA05
Tixocortol
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA06
Budesonid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EA07
Beclometason
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EB
Antiallergika, exkl. Corticosteroide
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EB01
Cromoglicinsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC
Aminosalicylsäure und ähnliche Mittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC01
Sulfasalazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC02
Mesalazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC03
Olsalazin
WHO Anatomical Therapeutic Chemical classification
0‑L
A07EC04
Balsalazid
WHO Anatomical Therapeutic Chemical classification
0‑L
A07F
Mikrobielle Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA
Mikrobielle Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA01
Milchsäurebildner
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA02
Saccharomyces boulardii
WHO Anatomical Therapeutic Chemical classification
0‑L
A07FA51
Milchsäurebildner, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07X
Andere Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA
Andere Antidiarrhoika
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA01
Albumintannat
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA02
Ceratonia
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA03
Calcium-haltige Verbindungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA04
Racecadotril
WHO Anatomical Therapeutic Chemical classification
0‑L
A07XA51
Albumintannat, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A08
Abmagerungsmittel, Exkl. Diätetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A08A
Abmagerungsmittel, Exkl. Diätetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA
Zentral wirkende Abmagerungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA01
Phentermin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA02
Fenfluramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA03
Amfepramon
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA04
Dexfenfluramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA05
Mazindol
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA06
Etilamfetamin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA07
Cathin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA08
Clobenzorex
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA09
Mefenorex
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA10
Sibutramin
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AA56
Ephedrin, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AB
Peripher wirkende Abmagerungsmittel
WHO Anatomical Therapeutic Chemical classification
0‑L
A08AB01
Orlistat
WHO Anatomical Therapeutic Chemical classification
0‑L
A09
Digestiva, Inkl. Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
A09A
Digestiva, Inkl. Enzyme
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA
Enzym-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA01
Diastase
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA02
Multienzyme (Lipase, Protease etc.)
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA03
Pepsin
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AA04
Tilactase
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB
Säure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB01
Glutaminsäurehydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB02
Betainhydrochlorid
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB03
Salzsäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AB04
Zitronensäure
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC
Enzym- und Säure-haltige Zubereitungen, Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC01
Pepsin- und Säure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A09AC02
Multienzyme und säure-haltige Zubereitungen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10
Antidiabetika
WHO Anatomical Therapeutic Chemical classification
0‑L
A10A
Insuline Und Analoga
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AA
Insulins
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB
Insuline und Analoga zur Injektion, schnell wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB05
Insulin aspart
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB06
Insulin glulisin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AB30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC
Insuline und Analoga zur Injektion, intermediär wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AC30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD
Insuline und Analoga zur Injektion, intermediär wirkend kombiniert mit schnell wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD04
Insulin lispro
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD05
Insulin aspart
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AD30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE
Insuline und Analoga zur Injektion, lang wirkend
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE02
Insulin (Rind)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE03
Insulin (Schwein)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE04
Insulin glargin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE05
Insulin detemir
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AE30
Kombinationen
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AF
Insuline und Analoga zur Inhalation
WHO Anatomical Therapeutic Chemical classification
0‑L
A10AF01
Insulin (human)
WHO Anatomical Therapeutic Chemical classification
0‑L
A10B
Antidiabetika, Exkl. Insuline
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA
Biguanide
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA01
Phenformin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA02
Metformin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BA03
Buformin
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB
Sulfonylharnstoff-Derivate
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB01
Glibenclamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB02
Chlorpropamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB03
Tolbutamid
WHO Anatomical Therapeutic Chemical classification
0‑L
A10BB04
Glibornurid
WHO Anatomical Therapeutic Chemical classification
Dieses Value Set beinhaltet 6063 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt.

Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavor OTH (other) schlägt Text in originalText vor. HL7 V3: NullFlavors werden im @nullFlavor Attribut statt in @code angegeben.
download XML JSON CSV SQL SVS